430 related articles for article (PubMed ID: 23927053)
1. Stereotactic ablative body radiotherapy for previously untreated solitary hepatocellular carcinoma.
Takeda A; Sanuki N; Eriguchi T; Kobayashi T; Iwabutchi S; Matsunaga K; Mizuno T; Yashiro K; Nisimura S; Kunieda E
J Gastroenterol Hepatol; 2014 Feb; 29(2):372-9. PubMed ID: 23927053
[TBL] [Abstract][Full Text] [Related]
2. Phase 2 study of stereotactic body radiotherapy and optional transarterial chemoembolization for solitary hepatocellular carcinoma not amenable to resection and radiofrequency ablation.
Takeda A; Sanuki N; Tsurugai Y; Iwabuchi S; Matsunaga K; Ebinuma H; Imajo K; Aoki Y; Saito H; Kunieda E
Cancer; 2016 Jul; 122(13):2041-9. PubMed ID: 27062278
[TBL] [Abstract][Full Text] [Related]
3. Stereotactic ablative radiotherapy for unresectable hepatocellular carcinoma patients who failed or were unsuitable for transarterial chemoembolization.
Lo CH; Huang WY; Lee MS; Lin KT; Lin TP; Chang PY; Fan CY; Jen YM
Eur J Gastroenterol Hepatol; 2014 Mar; 26(3):345-52. PubMed ID: 24384685
[TBL] [Abstract][Full Text] [Related]
4. Stereotactic body radiotherapy for small hepatocellular carcinoma: a retrospective outcome analysis in 185 patients.
Sanuki N; Takeda A; Oku Y; Mizuno T; Aoki Y; Eriguchi T; Iwabuchi S; Kunieda E
Acta Oncol; 2014 Mar; 53(3):399-404. PubMed ID: 23962244
[TBL] [Abstract][Full Text] [Related]
5. Comparison of Stereotactic Body Radiation Therapy Combined With or Without Transcatheter Arterial Chemoembolization for Patients With Small Hepatocellular Carcinoma Ineligible for Resection or Ablation Therapies.
Kimura T; Aikata H; Doi Y; Imano N; Takeuchi Y; Takahashi I; Nishibuchi I; Katsuta T; Kenjo M; Murakami Y; Awai K; Chayama K; Nagata Y
Technol Cancer Res Treat; 2018 Jan; 17():1533033818783450. PubMed ID: 29963972
[TBL] [Abstract][Full Text] [Related]
6. 18F-FDG PET and combined 18F-FDG-contrast CT parameters as predictors of tumor control for hepatocellular carcinoma after stereotactic ablative radiotherapy.
Huang WY; Kao CH; Huang WS; Chen CM; Chang LP; Lee MS; Chao HL; Chiu CH; Lo CH; Jen YM
J Nucl Med; 2013 Oct; 54(10):1710-6. PubMed ID: 23970365
[TBL] [Abstract][Full Text] [Related]
7. Repeated stereotactic ablative radiotherapy using CyberKnife for patients with hepatocellular carcinoma.
Lo CH; Huang WY; Lin KT; Lin MJ; Lin TP; Jen YM
J Gastroenterol Hepatol; 2014 Nov; 29(11):1919-25. PubMed ID: 25041220
[TBL] [Abstract][Full Text] [Related]
8. Stereotactic ablative radiotherapy in the treatment of hepatocellular carcinoma >3 cm.
Guarneri A; Franco P; Trino E; Campion D; Faletti R; Mirabella S; Gaia S; Ragona R; Diotallevi M; Saracco G; Salizzoni M; Ricardi U; Carucci P
Med Oncol; 2016 Oct; 33(10):104. PubMed ID: 27566310
[TBL] [Abstract][Full Text] [Related]
9. Stereotactic ablative radiotherapy versus conventionally fractionated radiotherapy in the treatment of hepatocellular carcinoma with portal vein invasion: a retrospective analysis.
Yang JF; Lo CH; Lee MS; Lin CS; Dai YH; Shen PC; Chao HL; Huang WY
Radiat Oncol; 2019 Oct; 14(1):180. PubMed ID: 31640728
[TBL] [Abstract][Full Text] [Related]
10. Stereotactic body radiation therapy as a salvage treatment for single viable hepatocellular carcinoma at the site of incomplete transarterial chemoembolization: a retrospective analysis of 302 patients.
Lee S; Jung J; Park JH; Kim SY; Choi J; Lee D; Shim JH; Kim KM; Lim YS; Lee HC; Park HH; Kim JH; Yoon SM
BMC Cancer; 2022 Feb; 22(1):175. PubMed ID: 35172769
[TBL] [Abstract][Full Text] [Related]
11. Two-week schedule of hypofractionated radiotherapy as a local salvage treatment for small hepatocellular carcinoma.
Park JH; Yoon SM; Lim YS; Kim SY; Shim JH; Kim KM; Lee HC; Cho B; Park G; Kim JH
J Gastroenterol Hepatol; 2013 Oct; 28(10):1638-42. PubMed ID: 23621519
[TBL] [Abstract][Full Text] [Related]
12. Long-Term Survival Analysis of Stereotactic Ablative Radiotherapy Versus Liver Resection for Small Hepatocellular Carcinoma.
Su TS; Liang P; Liang J; Lu HZ; Jiang HY; Cheng T; Huang Y; Tang Y; Deng X
Int J Radiat Oncol Biol Phys; 2017 Jul; 98(3):639-646. PubMed ID: 28581406
[TBL] [Abstract][Full Text] [Related]
13. Benefits of stereotactic ablative radiotherapy combined with incomplete transcatheter arterial chemoembolization in hepatocellular carcinoma.
Paik EK; Kim MS; Jang WI; Seo YS; Cho CK; Yoo HJ; Han CJ; Park SC; Kim SB; Kim YH
Radiat Oncol; 2016 Feb; 11():22. PubMed ID: 26896371
[TBL] [Abstract][Full Text] [Related]
14. Tumor response on CT following hypofractionated stereotactic ablative body radiotherapy for small hypervascular hepatocellular carcinoma with cirrhosis.
Sanuki N; Takeda A; Mizuno T; Oku Y; Eriguchi T; Iwabuchi S; Kunieda E
AJR Am J Roentgenol; 2013 Dec; 201(6):W812-20. PubMed ID: 24261388
[TBL] [Abstract][Full Text] [Related]
15. High-dose stereotactic body radiotherapy correlates increased local control and overall survival in patients with inoperable hepatocellular carcinoma.
Jang WI; Kim MS; Bae SH; Cho CK; Yoo HJ; Seo YS; Kang JK; Kim SY; Lee DH; Han CJ; Kim J; Park SC; Kim SB; Cho EH; Kim YH
Radiat Oncol; 2013 Oct; 8():250. PubMed ID: 24160944
[TBL] [Abstract][Full Text] [Related]
16. Local effect of stereotactic body radiotherapy for primary and metastatic liver tumors in 130 Japanese patients.
Yamashita H; Onishi H; Matsumoto Y; Murakami N; Matsuo Y; Nomiya T; Nakagawa K;
Radiat Oncol; 2014 May; 9():112. PubMed ID: 24886477
[TBL] [Abstract][Full Text] [Related]
17. Image-guided stereotactic ablative radiotherapy for the liver: a safe and effective treatment.
Van De Voorde L; Vanneste B; Houben R; Damen P; van den Bogaard J; Lammering G; Dejong K; de Vos-Geelen J; Buijsen J; Öllers M; Berbée M; Lambin P
Eur J Surg Oncol; 2015 Feb; 41(2):249-56. PubMed ID: 25468743
[TBL] [Abstract][Full Text] [Related]
18. Stereotactic body radiotherapy in patients with hepatocellular carcinoma in a multimodal treatment setting.
Gerum S; Heinz C; Belka C; Walter F; Paprottka PM; De Toni EN; Roeder F
Strahlenther Onkol; 2020 Apr; 196(4):334-348. PubMed ID: 31732784
[TBL] [Abstract][Full Text] [Related]
19. Comparing stereotactic ablative radiotherapy (SABR) versus re-trans-catheter arterial chemoembolization (re-TACE) for hepatocellular carcinoma patients who had incomplete response after initial TACE (TASABR): a randomized controlled trial.
Chen LC; Chiou WY; Lin HY; Lee MS; Lo YC; Huang LW; Chang CM; Hung TH; Lin CW; Tseng KC; Liu DW; Hsu FC; Hung SK
BMC Cancer; 2019 Mar; 19(1):275. PubMed ID: 30922261
[TBL] [Abstract][Full Text] [Related]
20. Stereotactic body radiation therapy combined with transcatheter arterial chemoembolization for small hepatocellular carcinoma.
Honda Y; Kimura T; Aikata H; Kobayashi T; Fukuhara T; Masaki K; Nakahara T; Naeshiro N; Ono A; Miyaki D; Nagaoki Y; Kawaoka T; Takaki S; Hiramatsu A; Ishikawa M; Kakizawa H; Kenjo M; Takahashi S; Awai K; Nagata Y; Chayama K
J Gastroenterol Hepatol; 2013 Mar; 28(3):530-6. PubMed ID: 23216217
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
